Bulletin of the Korean Chemical Society

  • 제32권2호
  • /
  • Pages.576-582
  • /
  • 2011
  • /
  • 0253-2964(pISSN)
  • /
  • 1229-5949(eISSN)
대한화학회 (Korean Chemical Society)
권호 표지
DOI QR코드

DOI QR Code

Anticonvulsant Activity of a Combined Pharmacophore of Pyrazolo-pyridines with Lesser Toxicity in Mice

  • Siddiqui, Nadeem (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University) ;
  • Ahsan, Waquar (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University) ;
  • Alam, M Shamsher (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University) ;
  • Ali, Ruhi (Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hamdard University) ;
  • Srivastava, Kamna (Center for Biomedical Research, University of Delhi) ;
  • Ahmed, Sharique (Department of Biochemistry, Faculty of Medicine, 7th October University)
  • 투고 : 2010.10.25
  • 심사 : 2010.12.07
  • 발행 : 2011.02.20
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Various 2-amino-6-[3-(substituted phenyl)-5-phenyl-4,5-dihydropyrazol-1-yl]-4-(substituted phenyl)nicotinonitriles (3a-t) were designed and synthesized by clubbing two active anticonvulsant pharmacophores pyrazole and pyridine. All the synthesized compounds possessed the pharmacophoric elements essential for good anticonvulsant activity. The anticonvulsant screening was performed by maximal electroshock seizure (MES) and subcutaneous pentylenetetrazole (scPTZ) tests. Two compounds 3i and 3s showed significant anticonvulsant activity in both the screens with $ED_{50}$ values 17.5 mg/kg and 22.6 mg/kg respectively in MES screen and 154.1 mg/kg and 242.6 mg/kg respectively in scPTZ screen. They were also found to have no acute toxic effects in mice when tested at elevated doses.

키워드

참고문헌

  1. Ozdemir, Z.; Kandilci, H. B.; Gümüşel, B.; Caliş, U.; Bilgin, A. A. Eur. J. Med. Chem. 2007, 42, 373-379. https://doi.org/10.1016/j.ejmech.2006.09.006
  2. Ozdemir, Z.; Burak, K. H.; Gumusel, B.; Calis, U.; Altan, B. A. Arch. Pharm. 2008, 341, 701-707. https://doi.org/10.1002/ardp.200800068
  3. Abdel-Aziz, M.; El-Din, A. G.; Hassan, A. A. Eur. J. Med. Chem. 2001, 44, 3480-3487.
  4. Lukevits, E. Chem. Heter. Comp. 1995, 31, 639-650. https://doi.org/10.1007/BF01169065
  5. Narendar, P.; Parthiban, J.; Anbalagan, N.; Gunasekaran, V.; Leonard, T. J. Biol. Pharm. Bull. 2003, 26, 182-187. https://doi.org/10.1248/bpb.26.182
  6. Bin, H.; Crider, A. M.; Stables, J. P. Eur. J. Med. Chem. 2001, 36, 265-286. https://doi.org/10.1016/S0223-5234(00)01206-X
  7. Kaminski, K.; Obniska, J.; Zagorska, A.; Maciag, D. Arch. Pharm. 2006, 339, 255-261. https://doi.org/10.1002/ardp.200500219
  8. Siddiqui, N.; Alam, P.; Ahsan, W. Arch. Pharm. 2009, 342, 173-181. https://doi.org/10.1002/ardp.200800130
  9. Mamolo, M. G.; Zampieri, D.; Falagiani, V.; Vio, L.; Banfi, E. IL Farmaco 2001, 56, 593-599. https://doi.org/10.1016/S0014-827X(01)01098-9
  10. Krall, R. L.; Penry, J. K.; White, B. G.; Kupferberg, H. J.; Swinyard, E. A. Epilepsia 1978, 19, 409-428. https://doi.org/10.1111/j.1528-1157.1978.tb04507.x
  11. Clark, C. R.; Wells, M. J. M.; Sansom, R. T.; Norris, G. N.; Dockens, R. C.; Ravis, W. R. J. Med. Chem. 1984, 27, 779-782. https://doi.org/10.1021/jm00372a013
  12. Litchfield, J. T.; Wilcoxon, F. J. Pharmacol. Exp. Ther. 1949, 96, 99-113.
  13. Dunham, N. W.; Miya, T. A. J. Am. Pharm. Assoc. Sci. 1957, 46, 208-209.
  14. Reitman, S.; Frankel, S. A. Am. J. Clin. Pathol. 1957, 28, 56-63.
  15. King, E. J.; Armstrong, A. R. Can. Med. Assoc. J. 1934, 31, 376-381.
  16. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. J. Comput. Chem. 1983, 4, 187-217. https://doi.org/10.1002/jcc.540040211
  17. Eddington, N. D.; Cox, D. S.; Roberts, R. R.; Butcher, R. J.; Edafiogho, I. O.; Stables, J. P.; Cooke, N.; Goodwin, A. M.; Smith, C. A.; Scott, K. R. Eur. J. Med. Chem. 2002, 37, 635-648. https://doi.org/10.1016/S0223-5234(02)01377-6

피인용 문헌

  1. ChemInform Abstract: Anticonvulsant Activity of a Combined Pharmacophore of Pyrazole-Pyridines with Lesser Toxicity in Mice. vol.42, pp.28, 2011, https://doi.org/10.1002/chin.201128142
  2. Overview on the synthetic routes to nicotine nitriles vol.48, pp.4, 2018, https://doi.org/10.1080/00397911.2017.1394468
  3. Synthesis and fluorescence properties of nicotinonitrile 1,2,3-triazole derivatives vol.67, pp.9, 2018, https://doi.org/10.1007/s11172-018-2280-7
  4. A Review: Synthesis and Medicinal Importance of Nicotinonitriles and Their Analogous vol.55, pp.7, 2018, https://doi.org/10.1002/jhet.3188
  5. Cinnamamide pharmacophore for anticonvulsant activity: evidence from crystallographic studies vol.74, pp.7, 2018, https://doi.org/10.1107/S2053229618007660
  6. Pyridine‐2( 1 H )‐thiones: Versatile precursors for one‐pot synthesis of new NICOTINONITRILE‐THIAZOLE hybrids vol.58, pp.7, 2011, https://doi.org/10.1002/jhet.4272